FIELD: chemistry.
SUBSTANCE: invention relates to novel peptides, constructed based on amino acid sequence corresponding to sequence of mature human lactoferrin from 13 to 30 amino acid residue having improved antimicrobial and/or anti-inflammatory activity, and their application, particularly for treating and/or preventing infections, inflammations, wounds or scars.
EFFECT: treatment and/or prevention of infections, inflammations, wounds or scars.
9 cl, 5 dwg, 8 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL SYNTHETIC PEPTIDES AND USE THEREOF | 2012 |
|
RU2596393C2 |
| SHORT ANTIMICROBIAL LIPOPEPTIDES | 2013 |
|
RU2627648C2 |
| NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-ASSOCIATED DISEASES, INCLUDING TREATMENT AND PREVENTION OF INFECTION BY MODULATING NATURAL IMMUNITY | 2006 |
|
RU2507213C2 |
| PEPTIDES WITH ANTAGONISTIC ACTIVITIES AGAINST NATURAL CXCR4 | 2014 |
|
RU2671708C2 |
| MUTATED LENTIVIRAL ENV PROTEINS AND THEIR USE AS DRUGS | 2012 |
|
RU2654673C2 |
| SHORT BIOLOGICALLY ACTIVE PEPTIDES FOR ACCELERATING WOUND HEALING | 2014 |
|
RU2606753C1 |
| STRUCTURED ANTI-TGF-BETA ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS | 2014 |
|
RU2681502C2 |
| MODULATION OF COMPLEMENT ACTIVITY | 2015 |
|
RU2670988C2 |
| IDENTIFICATION OF LYSINES AND THEIR DERIVATIVES WITH ANTIBACTERIAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA | 2018 |
|
RU2807688C2 |
| TREATMENT OF INFLAMMATION, AUTOIMMUNE, AND NEURODEGENERATIVE DISORDERS WITH IMMUNOSUPPRESSIVE TAT DERIVATIVE POLYPEPTIDES | 2013 |
|
RU2653754C2 |
